Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study

Patients with severe COVID-19 experience cytokine storm, an uncontrolled upregulation of pro-inflammatory cytokines, which if unresolved leads to acute respiratory distress syndrome (ARDS), organ damage, and death. Treatments with mesenchymal stromal cells (MSC) [Viswanathan S, Shi Y, Galipeau J, et...

Descripción completa

Detalles Bibliográficos
Autores principales: Grumet, Martin, Sherman, Jason, Dorf, Barry S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672850/
https://www.ncbi.nlm.nih.gov/pubmed/36181766
http://dx.doi.org/10.1093/stcltm/szac067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672850/
https://www.ncbi.nlm.nih.gov/pubmed/36181766
http://dx.doi.org/10.1093/stcltm/szac067

Ejemplares similares